IBRX Operating Cash Flow Growth
Immunitybio Inc · Operating Cash Flow Growth
IBRX Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported16.62%period ending
IBRX Quarterly Cash from Operations YoY % (-7945.05% → 16.62%)
Year-over-year change
High-resolution chart · PNG
IBRX operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 16.6178% | |
| 12.2764% | |
| 17.3424% | |
| 30.2299% | |
| 20.5298% | |
| 19.7014% | |
| 26.1358% | |
| -12.9973% | |
| -25.7907% | |
| -26.8912% | |
| -27.0526% | |
| -8.4404% | |
| 12.5795% | |
| -12.5184% | |
| -26.6447% | |
| -10.8422% | |
| -31.1186% | |
| -23.9147% | |
| -24.3646% | |
| -96.5775% | |
| -51.2212% | |
| -94.3903% | |
| -286.9936% | |
| -123.2139% | |
| -173.5009% | |
| -137.8575% | |
| -6.0714% | |
| 5.6855% | |
| -3.4489% | |
| 15.6856% | |
| -2.8812% | |
| -73.4037% | |
| -8.8027% | |
| -54.2309% | |
| -26.8483% | |
| 5.1484% | |
| -80.0988% | |
| -13.5614% | |
| 2.995% | |
| -155.6965% | |
| -205.0717% | |
| -20.9671% | |
| -333.6854% | |
| -492.6241% | |
| -35.9141% | |
| -7,945.0549% |